 |
| 5.11.2017 | AGENDA |
| | . |
| 12:30 – 1:30 | Registration & Networking |
| 1:30 – 1:40 | Welcome & Opening Remarks
Bob Buderi, Founder & CEO, Xconomy
Paul McKenzie, EVP for Pharmaceutical Operations and Technology, Biogen |
| 1:40 – 2:10 | Standing Up for Immigration and Diversity in Biotech
Tony Coles, Chairman & CEO, Yumanity Therapeutics
Susan Windham-Bannister, President and CEO, Biomedical Growth Strategies; Managing Partner, Biomedical Innovation Advisors
Jeremy Levin, CEO, Ovid Therapeutics; former CEO, Teva Pharmaceutical Industries
Teresa Lavoie, Partner, Fish & Richardson (moderator) |
| 2:10 – 2:35 | The Life Sciences in 2017 and Beyond: An Interactive Chat
Stelios Papadopoulos, Chairman of the Board, Biogen; Co-founder & Chairman of the Board, Exelixis
Bob Buderi, Founder & CEO, Xconomy |
| 2:35 – 3:05 | Battling the Opioid Crisis
Richard Pops, Chairman & CEO, Alkermes
Peter Koutoujian, Sheriff of Middlesex County, former member, Massachusetts House of Representatives |
| 3:05 – 3:35 | Patient-Centric Drug Development
Ed Kaye, President & CEO, Sarepta Therapeutics
Peter Saltonstall, President & CEO, National Organization for Rare Disorders
Abbie Celniker, Partner, Third Rock Ventures (moderator) |
| 3:35 – 4:05 | Break |
| 4:05 – 4:25 | Pioneering Life Science Ventures
Noubar Afeyan, Founder, Senior Managing Partner & CEO, Flagship Pioneering |
| 4:25 – 5:00 | Translating Science and Company Building: A Chat With Two Serial Entrepreneurs
Michael Gilman, CEO & Chairman, Arrakis Therapeutics
Katrine Bosley, CEO, Editas Medicine |
| 5:00 – 5:30 | Cancer Therapies of the Future
Laurie Glimcher, President & CEO, Dana-Farber Cancer Institute
David Schenkein, CEO, Agios Pharmaceuticals |
| 5:30 – 6:30 | Networking Reception |
